Ceva India team held “Cevac IBird Launch Program” on 3rd & 4th January 2022 at Namakkal & Coimbatore respectively. At Namakkal, 40 Veterinarians representing the layer markets attended this meeting. Whereas in Coimbatore around 30 Veterinarians & Integration key decision makers attended this meeting.
Both the meeting was constituted in two parts: launch meeting and technical session on Infectious Bronchitis.
Dr. Jayaraman K., Poultry Expert India & Subcontinent gave a review of the Infectious Bronchitis in India & Asia region and its effects on current Poultry Management. He emphasized on important point that IB variant is key concern for poultry production and current standard vaccination program is not sufficient to control the problem, so combination of standard vaccination of Mass strain along with IB variant strain must be practised to resolve the issue. This combination offers early, broad and long lasting protection against majority IB strains observed in India.
This session was followed by Dr. Saravana Perumal, National Veterinary Service Manager, Ceva India. He presented the new approach to “Control IB Disease” and highlighted the features, advantages, and benefits of Cevac IBird when combined with Cevac Vitabron L. The presentations induced high interest among the participants followed by many practical questions and fruitful discussion.
The overall objectives of this meeting were to showcase the Ceva innovative offerings, to secure and achieve additional business by introducing Cevac IBird – the first IB variant vaccine in India and to develop relationships with customers who have decision making or influencing power within their respective businesses. The South zone team will follow up with the customers to achieve successful sales of the complete Infectious Bronchitis vaccine range.